Back
Smith & Nephew plc Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Sell
50
SNNUF
Smith & Nephew plc
Last Price:
$16.90
Seasonality Move:
-1.71%
Sell
38
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.22
Seasonality Move:
-13.28%
Sell
50
Smith & Nephew plc (SNNUF)
is a Sell
Is Smith & Nephew plc a Buy, Sell or Hold?
-
The current Smith & Nephew plc [SNNUF] share price is $16.90. The Score for SNNUF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SNNUF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNNUF Stock Price Chart
What is Smith & Nephew plc's stock price today?
-
The Smith & Nephew plc share price today is $16.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNNUF is experiencing slight buying pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNNUF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.1 | Buy |
| Relative Strength Index (14 RSI): | 76.46 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.67 - 16.33) | Buy |
| Bollinger Bands (100): | (15.71 - 17.83) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 66.03 | Buy |
| Chaikin Money Flow: | 3428689 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.13 - 49.63) | Buy |
| Bollinger Bands (100): | (35.09 - 47.19) | Buy |
SNNUF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.39 | Buy |
| 20-day SMA: | 15.61 | Buy |
| 50-day SMA: | 15.95 | Buy |
| 200-day SMA: | 15.69 | Buy |
| 8-day EMA: | 16.01 | Buy |
| 20-day EMA: | 12.26 | Buy |
| 50-day EMA: | 6.92 | Buy |
| 200-day EMA: | 2.1 | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.2 | Buy |
| 20-day SMA: | 48.28 | Buy |
| 50-day SMA: | 45.42 | Buy |
| 200-day SMA: | 36 | Buy |
| 8-day EMA: | 48.68 | Buy |
| 20-day EMA: | 47.84 | Buy |
| 50-day EMA: | 45.56 | Buy |
| 200-day EMA: | 40.15 | Buy |
Smith & Nephew plc Earnings Growth & SNNUF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.
Smith & Nephew plc Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||